Moreover, in vivo studies showed that systemic application of DOX-HK-M nano-micelles was more efficient in inhibiting tumor growth than DOX-M or HK-M nano-micelles in a subcutaneous C6 glioma model, which was further confirmed by the staining of TUNEL, CD31, and Ki67 in tumor tissues. Here, PECAM1 is linked to glioma.